H.B. 2400 Summary

• Establishes a therapeutic psilocybin working group within the Department of Health to examine the medicinal and therapeutic effects of psilocybin and develop a long-term strategic plan for availability of therapeutic psilocybin products for adults 21 years and older.

• Working group must examine federal, state, and local laws regarding therapeutic psilocybin use; review medical and scientific studies on psilocybin's safety and efficacy in treating mental health conditions including addiction, depression, anxiety disorders, and end-of-life psychological distress; and examine prescribing requirements in other jurisdictions.

• Working group membership includes the Director of Health (chairperson), Attorney General, Dean of the John A. Burns School of Medicine, relevant legislative committee chairpersons, Hawaii State Council on Mental Health chairperson, licensed physicians or advanced practice registered nurses, psychiatrists, and other interested parties as invited.

• Working group members serve without compensation but receive reimbursement for necessary expenses including travel.

• Working group must submit findings, recommendations, and any proposed legislation to the legislature no later than twenty days before the 2023 regular session and dissolves on June 30, 2023; Act takes effect July 1, 2022.